<DOC>
	<DOC>NCT01303549</DOC>
	<brief_summary>The study is a randomized, open-label safety study comparing the use of anidulafungin (200 mg i.v. as initial dose and 100 mg/d i.v. in subsequent doses) vs liposomal amphotericin B (3 mg/kg/d i.v.) in hepatic transplant recipients who have high risk of fungal infection.</brief_summary>
	<brief_title>Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<mesh_term>Anidulafungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>At least 18 years old Signature of ICF Negative pregnancy test (women of child bearing potential) Patients who comply with at least one of the following (A or B): A: One of the following criteria (major criteria): Retransplant due to severe dysfunction of a previous hepatic graft Requirement of any renal substitutive therapy, including dialysis or hemofiltration Fulminant hepatitis requiring hepatic transplant B: Two of the following criteria (minor criteria): Posttransplant renal impairment (defined as CrCl&lt; 50 mL/min) 30 days after transplantation Intra surgery blood transfusion of at least 40 units Choledochal jejunectomy 2 or more Candida sp cultures (nasal, pharynx, rectal) from 48 hours pre to 48 hours posthepatic transplant Post transplant reintervention (laparotomy) Hypersensibility to amphotericin B or candin Patients who have received any other antifungal (excluding fluconazole or oral nystatin for a maximum of 7 days) Documented or suspected fungal infection Pregnant women of women who do not accept to us a valid anticonceptive method Any other disease or medical condition that makes the patient not adequate to participate in the trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Liver transplantation</keyword>
	<keyword>Hepatic transplant</keyword>
	<keyword>Antifungal prophylaxis</keyword>
	<keyword>Anidulafungin</keyword>
	<keyword>Liposomal Amphotericin B</keyword>
</DOC>